This article is available to subscribers. Subscribe now. Already have an account? Sign in

CorrespondenceFree Preview

Human GM-CSF Autoantibodies and Reproduction of Pulmonary Alveolar Proteinosis

To the Editor: Idiopathic pulmonary alveolar proteinosis is a rare disease in which surfactant lipids and proteins accumulate in pulmonary alveolar macrophages and alveoli, resulting in respiratory insufficiency and, in severe cases, respiratory failure.1 Granulocyte–macrophage colony-stimulating factor (GM-CSF) autoantibodies occur in these patients2 and may mediate the pathogenesis of this disease, but they are also present in healthy persons and in immune globulin prepared from plasma obtained from healthy persons. Since GM-CSF is required for surfactant catabolism by alveolar macrophages in mice, we hypothesized that high levels of GM-CSF autoantibodies (i.e., levels sufficient to eliminate endogenous GM-CSF priming of myeloid . . .

Continue reading this article

Select an option below:

Create your account to get 2 free subscriber-only articles each month.

Get Free Access Now Subscribe For Full Access

Already have an account?

Sign In

Print subscriber?

Activate your online access.

Takuro Sakagami, M.D., Ph.D.
Kanji Uchida, M.D., Ph.D.
Takuji Suzuki, M.D., Ph.D.
Brenna C. Carey, Ph.D.
Robert E. Wood, M.D., Ph.D.
Susan E. Wert, Ph.D.
Jeffrey A. Whitsett, M.D.
Bruce C. Trapnell, M.D.
Cincinnati Children's Hospital Medical Center, Cincinnati, OH

Maurizio Luisetti, M.D.
University of Pavia, Pavia, Italy

Funding and Disclosures

Supported in part by grants from the National Heart, Lung, and Blood Institute (HL085453, to Dr. Trapnell) and the National Center for Research Resources and the Office of Rare Diseases of the National Institutes of Health (RR019498, to Dr. Trapnell).

Dr. Wood reports receiving grant support from Olympus. No other potential conflict of interest relevant to this letter was reported.

Print Subscriber? Activate your online access.